The PAS Annual General Meeting will be held on May 4, 2019. The agenda includes:
1. Welcome from the Chair and approval of the agenda
2. Introduction of the 2019-2020 board members
3. Approval of minutes from 2018 and any business arising
4. Presentation and approval of the 2017-2018 financial statements and appointment of auditor
5. Reports from the Chair, CEO, Director of Professional Practice, CPhA representative, and committees
6. New business and adjournment.
Championing Sustainability, Namibia Funds Health AccountsHFG Project
In Namibia, donor funding for health dropped by 47 percent between 2009 and 2013. This sharp decline could have broad implications for the health sector—particularly Namibia’s HIV and AIDS response which relies heavily on donor resources. In light of declining donor resources for health, the Government of Namibia (GRN) is positioning itself to sustain health sector progress to-date, through investing in Health Accounts.
Burundi’s Health Accounts Data Underline Need for Health Financing ReformsHFG Project
Faced with a double burden of disease, Burundi’s government is grappling with how to address growing demand for health care. At the same time, the government is working to balance financial constraints, rising costs, and limited resources. Policymakers need access to the reliable data to make well-informed decisions to raise sufficient funds for the health sector, allocate them according to need, and manage the burden of health costs on households.
For more than a year, the Health Finance and Governance Project (HFG) has worked closely with Burundi’s Health Accounts team to build their capacity to use HA and the SHA 2011 framework. The team is housed in the Planning Unit of the Ministry of Health and Fight Against HIV/AIDS (MSPLS). As a result, MSPLS now has the expertise to produce HAs going forward with minimal external assistance.
Developing Haiti’s First Health Financing StrategyHFG Project
The Ministry has an approved National Health Policy, known as the Politique Nationale de Santé, which addresses “what” is to be done. In addition, the Ministry is developing a National Health Plan that lays out “how” the National Health Policy will be made operational. However, the Ministry of Health does not yet have a national health financing strategy that outlines “where” resources will come from and “how” they will be used to achieve the country’s health objectives.
To bridge this important gap, the HFG project is working with the Planning and Evaluation Unit of the Ministry of Health to develop a national health financing strategy that will include an operational plan consisting of specific activities, timelines, and an overall health budget. The strategy will focus on the three core functions of health financing: mobilization of resources; pooling of risks and financial protection; and purchasing and provider payment. A strategy mapping out these core health financing functions will enable Haiti to raise the necessary resources, better protect people from the financial consequences of ill health, and make optimum use of resources to achieve the National Health Plan’s vision.
The health financing strategy will serve as a road map, particularly when it is combined with data from the second National Health Accounts, which the HFG project is also supporting, and a fully costed National Health Plan. Together, they will provide strong evidence and powerful justification for increased health financing in the future to improve Haiti’s health outcomes.
Botswana Health Accounts 2013-14: Key Findings and ImplicationsHFG Project
The Botswana 2013/14 HA exercise was conducted between July 2015 and September 2016. The study covers the 2013/14 fiscal year (1 April 2013–31 March 2014). In mid-2015, the HA team, with representation from the Government of Botswana, the Health Finance and Governance (HFG) project, and the World Health Organization (WHO), began primary and secondary data collection. Collected data were then compiled, cleaned, triangulated, and reviewed. Data were imported into the HA Production Tool (HAPT) and mapped to each of the System of Health Accounts (SHA) 2011 classifications. The results of the analysis were verified with the Health Financing Technical Working Group on 9 October 2016 and the Ministry of Health and Wellness (MoHW) management on 10 October 10 2016. Participants involved in the production and validation of the results, and recommended for future HA workshops, are listed in Annex A.
Delivering clinical and financial sustainability across a £6bn health economy...NHS England
Expo is the most significant annual health and social care event in the calendar, uniting more NHS and care leaders, commissioners, clinicians, voluntary sector partners, innovators and media than any other health and care event.
Expo 15 returned to Manchester and was hosted once again by NHS England. Around 5000 people a day from health and care, the voluntary sector, local government, and industry joined together at Manchester Central Convention Centre for two packed days of speakers, workshops, exhibitions and professional development.
This year, Expo was more relevant and engaging than ever before, happening within the first 100 days of the new Government, and almost 12 months after the publication of the NHS Five Year Forward View. It was also a great opportunity to check on and learn from the progress of Greater Manchester as the area prepares to take over a £6 billion devolved health and social care budget, pledging to integrate hospital, community, primary and social care and vastly improve health and well-being.
More information is available online: www.expo.nhs.uk
Delivering clinical and financial sustainability, pop up uni, 2 september 2015NHS England
Expo is the most significant annual health and social care event in the calendar, uniting more NHS and care leaders, commissioners, clinicians, voluntary sector partners, innovators and media than any other health and care event.
Expo 15 returned to Manchester and was hosted once again by NHS England. Around 5000 people a day from health and care, the voluntary sector, local government, and industry joined together at Manchester Central Convention Centre for two packed days of speakers, workshops, exhibitions and professional development.
This year, Expo was more relevant and engaging than ever before, happening within the first 100 days of the new Government, and almost 12 months after the publication of the NHS Five Year Forward View. It was also a great opportunity to check on and learn from the progress of Greater Manchester as the area prepares to take over a £6 billion devolved health and social care budget, pledging to integrate hospital, community, primary and social care and vastly improve health and well-being.
More information is available online: www.expo.nhs.uk
Central coordination for Financing UHC in Nigeria: Progress and Next StepsHFG Project
Presented during Day One of the 2016 Nigeria Health Care Financing Training Workshop. Presented by Dr. Francis Ukwuije. More: https://www.hfgproject.org/hcf-training-nigeria
This presentation by Akiko MAEDA and Cheryl CASHIN was made at the 3rd Joint DELSA/GOV Health Meeting, Paris 24-25 April 2014. Find out more at www.oecd.org/gov/budgeting/3rdmeetingdelsagovnetworkfiscalsustainabilityofhealthsystems2014.htm
Championing Sustainability, Namibia Funds Health AccountsHFG Project
In Namibia, donor funding for health dropped by 47 percent between 2009 and 2013. This sharp decline could have broad implications for the health sector—particularly Namibia’s HIV and AIDS response which relies heavily on donor resources. In light of declining donor resources for health, the Government of Namibia (GRN) is positioning itself to sustain health sector progress to-date, through investing in Health Accounts.
Burundi’s Health Accounts Data Underline Need for Health Financing ReformsHFG Project
Faced with a double burden of disease, Burundi’s government is grappling with how to address growing demand for health care. At the same time, the government is working to balance financial constraints, rising costs, and limited resources. Policymakers need access to the reliable data to make well-informed decisions to raise sufficient funds for the health sector, allocate them according to need, and manage the burden of health costs on households.
For more than a year, the Health Finance and Governance Project (HFG) has worked closely with Burundi’s Health Accounts team to build their capacity to use HA and the SHA 2011 framework. The team is housed in the Planning Unit of the Ministry of Health and Fight Against HIV/AIDS (MSPLS). As a result, MSPLS now has the expertise to produce HAs going forward with minimal external assistance.
Developing Haiti’s First Health Financing StrategyHFG Project
The Ministry has an approved National Health Policy, known as the Politique Nationale de Santé, which addresses “what” is to be done. In addition, the Ministry is developing a National Health Plan that lays out “how” the National Health Policy will be made operational. However, the Ministry of Health does not yet have a national health financing strategy that outlines “where” resources will come from and “how” they will be used to achieve the country’s health objectives.
To bridge this important gap, the HFG project is working with the Planning and Evaluation Unit of the Ministry of Health to develop a national health financing strategy that will include an operational plan consisting of specific activities, timelines, and an overall health budget. The strategy will focus on the three core functions of health financing: mobilization of resources; pooling of risks and financial protection; and purchasing and provider payment. A strategy mapping out these core health financing functions will enable Haiti to raise the necessary resources, better protect people from the financial consequences of ill health, and make optimum use of resources to achieve the National Health Plan’s vision.
The health financing strategy will serve as a road map, particularly when it is combined with data from the second National Health Accounts, which the HFG project is also supporting, and a fully costed National Health Plan. Together, they will provide strong evidence and powerful justification for increased health financing in the future to improve Haiti’s health outcomes.
Botswana Health Accounts 2013-14: Key Findings and ImplicationsHFG Project
The Botswana 2013/14 HA exercise was conducted between July 2015 and September 2016. The study covers the 2013/14 fiscal year (1 April 2013–31 March 2014). In mid-2015, the HA team, with representation from the Government of Botswana, the Health Finance and Governance (HFG) project, and the World Health Organization (WHO), began primary and secondary data collection. Collected data were then compiled, cleaned, triangulated, and reviewed. Data were imported into the HA Production Tool (HAPT) and mapped to each of the System of Health Accounts (SHA) 2011 classifications. The results of the analysis were verified with the Health Financing Technical Working Group on 9 October 2016 and the Ministry of Health and Wellness (MoHW) management on 10 October 10 2016. Participants involved in the production and validation of the results, and recommended for future HA workshops, are listed in Annex A.
Delivering clinical and financial sustainability across a £6bn health economy...NHS England
Expo is the most significant annual health and social care event in the calendar, uniting more NHS and care leaders, commissioners, clinicians, voluntary sector partners, innovators and media than any other health and care event.
Expo 15 returned to Manchester and was hosted once again by NHS England. Around 5000 people a day from health and care, the voluntary sector, local government, and industry joined together at Manchester Central Convention Centre for two packed days of speakers, workshops, exhibitions and professional development.
This year, Expo was more relevant and engaging than ever before, happening within the first 100 days of the new Government, and almost 12 months after the publication of the NHS Five Year Forward View. It was also a great opportunity to check on and learn from the progress of Greater Manchester as the area prepares to take over a £6 billion devolved health and social care budget, pledging to integrate hospital, community, primary and social care and vastly improve health and well-being.
More information is available online: www.expo.nhs.uk
Delivering clinical and financial sustainability, pop up uni, 2 september 2015NHS England
Expo is the most significant annual health and social care event in the calendar, uniting more NHS and care leaders, commissioners, clinicians, voluntary sector partners, innovators and media than any other health and care event.
Expo 15 returned to Manchester and was hosted once again by NHS England. Around 5000 people a day from health and care, the voluntary sector, local government, and industry joined together at Manchester Central Convention Centre for two packed days of speakers, workshops, exhibitions and professional development.
This year, Expo was more relevant and engaging than ever before, happening within the first 100 days of the new Government, and almost 12 months after the publication of the NHS Five Year Forward View. It was also a great opportunity to check on and learn from the progress of Greater Manchester as the area prepares to take over a £6 billion devolved health and social care budget, pledging to integrate hospital, community, primary and social care and vastly improve health and well-being.
More information is available online: www.expo.nhs.uk
Central coordination for Financing UHC in Nigeria: Progress and Next StepsHFG Project
Presented during Day One of the 2016 Nigeria Health Care Financing Training Workshop. Presented by Dr. Francis Ukwuije. More: https://www.hfgproject.org/hcf-training-nigeria
This presentation by Akiko MAEDA and Cheryl CASHIN was made at the 3rd Joint DELSA/GOV Health Meeting, Paris 24-25 April 2014. Find out more at www.oecd.org/gov/budgeting/3rdmeetingdelsagovnetworkfiscalsustainabilityofhealthsystems2014.htm
Paseka Baptista Ramashamole, Deputy Executive Director of the Christian Health Association of Lesotho (CHAL) discusses CHAL's partnership with the government of Lesotho to provide health care at the 2018 CCIH conference.
Delivered by Prof Frances Ruane, Chairperson of the Expert Group on Resource Allocation in the Health Sector, Executive Director of the ESRI at the IPHA Annual Meeting 2010.
Dr Judith Smith, Director of Policy at the Nuffield Trust, on why pharmacy needs to act now to ensure that it doesn't miss out on delivering front-line care.
IMPLEMENTATION OF A SUCCESSFUL HEALTH MANAGEMENT STRATEGYHuman Capital Media
Cherokee County, Georgia, Board of Commissioners together with their consultant, Insurance Office of America, began the process of developing a health management strategy, or HMS, for their self-funded employee benefits program. The county’s plan was bundled with a national carrier and had been in the red financially for many years. The objectives were to reduce spend in the health plans without reducing coverage nor increasing employee premiums. Further, it was the county’s desire to maintain the current network of providers, to improve engagement with their health plan members and to improve the overall perception of the employee benefits program. The county’s final goal was to then develop a long-term strategic plan for their employee benefits program. Developing and deploying an HMS is an integral part of the solution because it is designed to allow for the bolt-on application of new, creative, risk-management-type vendors who could add value to the plan while lowering spend for the county. This was achieved by unbundling services from the carrier and implementing six new best-in-class vendors enhancing coverage where all but one was voluntary in nature, meaning the health plan members didn’t have to use them.
Learning Objectives/Session Takeaways:
Innovative health management strategy designs for self-funded plans.
Change management: buy-in from key stakeholders, reccurring education and strategic communications to plan members.
Top talent: Authentic teamwork and partnership are key.
National health accounts - Gerlie Lie, The Global FundOECD Governance
This presentation was made by Gerlie Lie, The Global Fund, at the 2nd Health Systems joint Network Meeting for Central, Eastern and Southeastern European Countries held in Tallinn, Estonia, on 1-2 December 2016
On 4th December 2015 the Big Lottery Fund and CBO evaluation team ran a peer learning event for people developing SIBs related to employment, housing and crime. These slides are from the afternoon workshop by Staffordshire Country Council and Social Finance describing the development of their MHEP SIB supporting adults with mental health problems into employment.
A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...PASaskatchewan
As pharmacists, you are rarely faced with a consistent patient population with similar problems and questions. More likely, each patient you interact with has unique and varied concerns that you must be ready to address in an instant. This session reflects the diversity of patients a pharmacist will face in day-to-day practice and covers a range of topics in a quick and snappy format. This session will cover the evidence as it relates to concurrent probiotic and antibiotic use, second line treatment for patients with type 2 diabetes, and explore new utilization strategies of using drugs traditionally used in the treatment of type 2 diabetes for patients with type 1 diabetes.
Pharmacists will soon be able to offer comprehensive travel consultations including prescribing travel-related vaccines. This session will serve as an introduction to the topic by taking you through the most common questions faced in community pharmacy.
Preventing Opioid Overdose Deaths with Take-home Naloxone/ NIHB PolicyPASaskatchewan
An overview of Take Home Naloxone including who should be counselled, some counselling tips and most importantly how to recognize and respond to an opioid overdose using Naloxone. We will finish off the discussion with Non-Insured Health Benefits (NIHB) coverage and where to go when you have questions or difficulties in obtaining drug coverage for your patients.
This session will help pharmacists enhance their expertise in managing patients with hypertension through updates on the latest hypertension guidelines, discussion on the role that pharmacists can and should play in the detection and ongoing management of hypertension and hands-on experience with blood pressure measurement devices.
Saskatchewan Transfer Discharge Medication Reconciliation Form OverviewPASaskatchewan
A discussion of the provincial transfer/discharge medication reconciliation form from acute care facilities. We will discuss the form in the current state and the purpose of the form when presented to community pharmacies across the province. This discussion will help gain an understanding of the patients “story” of medications utilized prior to admission to hospital, what medications were utilized in hospital and what medications the patient is to continue after discharge. The session will help community pharmacists understand what medications are to be dispensed from the form. The understanding of the use of the form will allow community pharmacies to provide a continuity of care of the patient in the transition from an acute care facility to their community home.
A review of pharmacist-led transition of care systems, specifically post-discharge follow-up phone calls, and the opportunity for pharmacy students to lead a new service. A review of the “Post-Discharge Follow-up Phone Call SPEP Standard Work” project will be provided, including an overview of the methodology, results, and discussion.
Pharmacists will soon be able to offer comprehensive travel consultations including prescribing travel-related vaccines. This session will serve as an introduction to the topic by taking you through the most common questions faced in community pharmacy.
Inhaled Medications Used in Respiratory DiseasePASaskatchewan
Inhaled Medications used in Respiratory Disease Donna Turner, BSc, RRT, CRE Community Respiratory Care Program, Cooperative Health Centre, Prince Albert
A presentation on inhaled medication devices new and old. What to consider ensuring maximal drug delivery to your patients and how help choose the best device for each patient. Will also show resources available for clinicians to use in their practice.
Medicine Plants- Medicinal Ceremony - Elder Betty McKenna, Instructor FNU of Canada
Session touches on the importance of medicine plants and medicinal ceremony in the indigenous practice of Medicine wheel wellness.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
2. Agenda
1. Welcome from the Chair
2. Introduction of 2014-15 PAS Board
Members
Communication of Chair and Vice-Chair
3. Business Arising from 2013 Minutes
1. Welcome from PAS Chair 2. Approval of AGM 2019 Agenda.
3. Introduction of 2019-2020 PAS Board
Members
• Chair/Vice-Chair Announcement
• CPhA Board Representative
4. Motion to Accept 2018 Minutes as printed
and distributed
5. Business Arising from 2018 Minutes 6. Financial Matters
• Approval of 2017-18 Audited Financial
Statements
• Appointment of PAS Auditor
7.Reports
• Chair’s Report
• CEO’s Report
• Director of Professional Practice Report
• CPhA Representative Report
• Committee Reports (in Annual Reports)
8. New Business
9. Adjournment
4. Announcement of PAS 2019-2020
Board of Directors
John Stanzeleit (Chair) George Furneaux (Vice-Chair)
Paul Bazin (Past Chair) Amy Lamb
Warren Delmage Lindsey Ziegler
Monique Swack Robyn Despins
Cordell Hilderman
Dr. Kishor Wasan, Dean, College of
Pharmacy and Nutrition (until July
2019)
Laura Almas CSHP – SK Branch
Palima Shrestha, Senior Stick
Student Representative (until
Sept. 1)
Christine Hrudka – CPhA Board
Representative
Elected Members:
Appointed Members:
7. Financial Matters
Approval of the 2017-18 Audited Financial
Statements (Meyers, Norris and Penney)
contained within the new PAS Annual Report (on
tables)
Appointment of Auditor (recommending Meyers,
Norris and Penney)
8. Highlights:
membership numbers stayed relatively consistent with incremental
growth in 2017-18.
Excess of revenues over expenses: $71,400 (6% of total
revenues)
Operating expenses increased by $56,833 (6%) primarily due to
advocacy, issues mgmt, and public education initiatives approved
by Board but also additional transition costs on building occupancy
between old office and new, and increased salary costs.
Staffing and Benefits largest portion of costs: approximately 41%
of overall costs ($468,429)
Board directed transfer of cumulative operational surpluses to
investments account (emergency fund) so account now just over
500K
2017-18 Audited Statements
9. Motion to approve 2017-18
statements as presented and
provided
Approval of Financial Statements
10. Recommending re-appointment of Meyers,
Norris, Penney as PAS Auditor for 2018-19
fiscal year.
(motion to re-appoint)
Appointment of Auditor
11. Reports
PAS Chair Report
CEO’s Report
Director of Professional Practice’s Report
CPhA Representative Report
Current Year Committee Reports
* More detailed reports are in the printed annual
reports
12. Highlights:
Continued pressures on the pharmacy business model. Generic pricing agreement, wholesalers agreement,
e-prescribing push, regulatory changes, third-party pressures, and more.
New contract finalized in October 2018 – although best in Canada at the time, more work to be done on pharmacist
role and financial enablers.
Advocacy Initiatives: PAS continues to bring pharmacist voice to tables including regulatory tables, PrescribeIT,
third party payors (through national 3rd party payor working group), physicians, and others.
Public Education: reduced but significant flu shot and minor ailment campaigns but also new this year, PAS utilized
public education “Rethink Pharmacists” campaign this year during PAM. This was the first time many provinces ran a
collective campaign using the same tools. Creates a national look to some advocacy/public education.
Continued change is the only constant: National Pharmacare, continued economic pressures, practice change
(eg. Travel health), regulatory changes, ….
The PAS Board and Staff are working hard for you – make sure you stay connected by having a membership!
Report from the Chair
13. Highlights:
• Working with the PAS Economics Committee, we have had sustained advocacy and preparation work for pharmacy
contract negotiations which culminated in the new one-year contract. Also worked with federal government to match
new professional fee. We have begun the process again and will begin meetings before summer.
• Providing feedback to SCPP regarding scope of practice and proposed regulatory changes. SCPP continues to
collaborate with PAS to enable feedback on important initiatives.
• Public education campaigns on flu shots and minor ailments and generalized campaign “Health care in Saskatchewan
needs to see a pharmacist”
• Responding (again) to physician actions related to concerns on new self-care/minor ailments.
• Renewed planning and risk identification and management for the Association. Some disturbing trends with reducing
membership are predicted.
• Multitude of small and large initiatives to manage, including flu vaccine supply management, new SCA PACT
partnership, SMAP audit communications, and provincial and national media and policy issues.
Report from the CEO
14. Provincial Flu Vaccination Program
First year of Expanded program:
home visits and congregate living
Reduced mobility/access (excluding LTC homes)
patients age 5 and up (in-line with Bylaws for injecting)
As of February March 31, 2019, 154,892 flu shots administered (last year 118,050)
Up 32% from 2017-18
Up 71% from 2016-17
Up 178% from 2015-16
Reminders: All reports are to be sent in immediately
Notification of Vaccine Administration, Product Wastage, Cold Chain, AEFI, Vaccine supply problem
Travel Health and Vaccinations
Collaborating with SCPP, Ministry, DPEBB, CPDPP at various stages throughout the process
PACT
Created a partnership with Saskatchewan Cancer Agency (SCA)
Referring patients requiring PACT counseling and/or tobacco cessation prescribing to community PACT pharmacists
Updating several modules including Oncology, Quitting Commercial Tobacco, Youth
Training now housed at CPDPP
PACT website migration to PAS website underway
Report from the Director of
Professional Practice
15. Minor Ailment Expansion*
Injection Administration Fee- New*
Medroxyprogesterone actetate injectable suspension 150mg/ml
Total Billable Services $9,750,282 ($8,784,282 in 2017-18)
Minor ailments $501,647 ($300,635)
Influenza Immunization Fee $2,033,356 ($1,531,996)
Injection Administration Fee $14,639 (N/A)
Pharmacy Professional Services
Fiscal 2018-19
DPEBB Fiscal Year April 1- March 31
*Starting Nov 1
**Starting Dec 6
Conjuctivitis Obesity
Emergency Contraception Onychomycosis
Erectile Dysfunction Shingles
Hormonal Contraception Uncomplicated UTI
Influenza Tobacco Cessation**
16. In the Annual Report, more details on the following:
Expanded Influenza program support documents and communications
Guide for Vaccine Screening Tool and Consent form Questions and Guide
Minor Ailment, Self-care and Preventable Disease support material
NIHB Pharmacists Initiated Treatment document
National Third Party Payor Working Group
Work of the Professional Practice Committee
Collaboration with the DPEBB on improving the SMAP program
Student support
Saskatchewan Health Authority collaboration on Discharge/Transfer forms
Report from the Director of
Professional Practice
17. Report from CPhA Board
Representative (Christine Hrudka)
CPhA Report
If time running out, CEO and DOP reports summarized in handouts.
- Minor Ailments, Self-care and Preventable Diseases.
CPhA’s new membership and governance model were approved in June 2014.
PAS joined CPhA as an Organizational Member, effective July 1, 2014.
I’m going to take just a few minutes today to give you an brief overview of CPhA’s activities in 2015.
CPhA did a lot of great work in 2018, and worked very hard to continue to build collaborative relationships with our Organizational Members
Throughout 2018, CPhA continued to prioritize activities related to our 2017-2020 Strategic Plan that supports CPhA’s mission and vision.
This plan is built on a foundation of delivering member value, and focuses on three main areas:
Advocate for pharmacists
Advance the profession to enhance patient care
Ensure that CPhA has the financial capacity to deliver on its mission and vision
Throughout 2018, advocating for pharmacists remained a primary focus for CPhA.
We continued to work collaboratively with our members to bring a strong, united voice for pharmacists to the table and we made recommendations to government on issues including:
improving drug access for Canadians,
addressing the opioid crisis,
convening national stakeholders to resolve drug shortage issues and
including pharmacists as key players in the management of medical cannabis use of their patients.
In addition, CPhA worked closely with our members on both the 2018 PAM campaign, as well as the Image and Reputation Collaborative, a national, coordinated campaign to highlight the key role pharmacists play in the health care system. WE rolled out this campaign, Rethink Pharmacists, in the early part of 2019 – I hope you’ve seen it! – and will continue to build on this over the next couple of years.
We also continued to build economic capacity this year with the establishment of an Economics Advisory Group who have been tasked with the identification of high value services that can be supported by evidence to guide decision making for public funding. We released a couple of big research reports last year, including The Pharmacist in Your Neighbourhood: The Economic Footprint of Canada’s Community Pharmacy Sector, which highlighted the unique ways pharmacy contributes to the overall wealth of Canada.
Our second strategic priority is to advance the profession, and helping pharmacists increase their confidence to deliver enhanced pharmacy services is a big part of that goal.
We released two new CPD programs in 2018:
- Managing Your Pharmacy: The Business Essentials and
-Cannabis: Applying the Evidence to Practice
These programs join our suite of online self-directed programs that are available free or discounted for members.
New this year, we also accredited several conference recordings from our 2018 conference held in Fredericton.
We also delivered 9 webinars to more than 2100 pharmacists with another 400 views of recorded webinars in our archives.
2018 webinars covered:
pharmacists on the diabetes care team
non-prescription therapies for fever and pain management in children
drug pricing reform and pharmacare
protecting your patients from HPV
Choosing Wisely
partnering with patients in medication safety
prevention and management of statin-associated myopathy
the pharmacists’ role in medical abortion and
the role of non-statin therapy in the management of dyslipidemia.
CPhA’s webinars are usually a free and exclusive member benefit.
.
Over the course of 2018, CPhA continued to enhance its online suite of drug and therapeutic information.
In addition to the publication of new editions of our four core drug and therapeutic references this year, we released RxTx mobile 5.0, which features significant design changes and functionality improvements designed to help users find information faster and more efficiently.
We also moved forward with a number of new services this year to both maximize our already trusted content and help diversify our business portfolio. CPS Notifications, a digital repository for clinically relevant information on drug products in Canada, was launched in September; and the RxTx Integration Solution, designed to provide third-party clinical management systems with trusted content, continues to roll out across the country. This year, CPhA was also pleased to announce an investment in Pharmapod, a medication error reporting platform that is already playing a vital role in improving patient safety and supporting pharmacists around the world in tracking and reducing medication errors.
In terms of member value and benefits, CPhA continued to provide the CPJ to all PAS members throughout 2018. The Cross-Canada Updates feature in the CPJ was a new initiative throughout the year, where each CPhA Organizational Member, including PAS, submitted a short paragraph highlighting recent activities. We’ve continued with this feature in 2019.
We also continued to offer a range of affinity programs in partnership with our member organizations, including discounts at GoodLife Fitness, VIA Rail Canada, Choice Hotels and the American Pharmacists Association, as well as a partnership with Telus Mobility through the BCPhA.
We were also very pleased to bring accredited CE session to almost all Organizational Member conferences in 2018, including a session on hypertension that Phil Emberley delivered at the 2018 PAS conference.
The Women in Pharmacy Leadership initiative was launched in March of this year with a report on the current landscape here in Canada.
You may or may not be aware of the fact that women are generally over-represented at the staff level, but under-represented among managers and even more among owners.
As I begin my second year as Chair of CPhA, I’m really focused on mentoring and increasing women in leadership positions across the country. You can’t be what you can’t see, and we’re working hard, together, to move the bar in this area.
We’ll be undertaking additional research, and we hope that you’ll be joining us at the Women in Pharmacy Leadership Summit in Toronto on June 2, just ahead of our 2019 national conference, Pharmacy Experience Pharmacie from June 3-5.
Thank you for your continued support over the past year. We’re looking forward to continuing our good work together this through 2019.